Doctoral Researcher


Name Hannah Manz
Affiliation
Center for Experimental Molecular Medicine (ZEMM)
Street Zinklesweg 10
Zip Code 97078
City Würzburg
Email E-mail
Telephone
Homepage Homepage
Section Infection & Immunity
Title of Thesis Project Targeting multiple myelomawithin its bone marrowniche Deciphering multiple myeloma-bone marrow interactions
Primary Supervisor Dr. Andreas Brandl now Universitätsklinikum Heidelberg
Member of Thesis Committee Prof. Dr. Andreas Beilhack
Prof. Dr. Manfred Lutz
Dr. Miodrag Gužvić, University of Regensburg
Conference Contribution
Publication

Junctional adhesion molecule C expression specifies a CD138low/neg multiple myeloma cell population in mice and humans. Brandl A, Solimando AG, Mokhtari Z, Tabares P, Medler J, Manz H, Da Vià MC, Croci GA, Kurzwart M, Thusek S, Schneider T, Ebert R, Jakob F, Einsele H, Beilhack A. Blood Adv. 2022 Apr 12;6(7):2195-2206. doi: 10.1182/bloodadvances.2021004354.

 

Transient regulatory T-cell targeting triggers immune control of multiple myeloma and prevents disease progression. Dahlhoff J, Manz H, Steinfatt T, Delgado-Tascon J, Seebacher E, Schneider T, Wilnit A, Mokhtari Z, Tabares P, Böckle D, Rasche L, Martin Kortüm K, Lutz MB, Einsele H, Brandl A, Beilhack A. Leukemia. 2022 Mar;36(3):790-800. doi: 10.1038/s41375-021-01422-y. Epub 2021 Sep 28.

 

A Hyperactive Form of the Zinc Cluster Transcription Factor Stb5 Causes YOR1 Overexpression and Beauvericin Resistance in Candida albicans. Ramírez-Zavala B, Manz H, Englert F, Rogers PD, Morschhäuser J. Antimicrob Agents Chemother. 2018 Nov 26;62(12):e01655-18. doi: 10.1128/AAC.01655-18. Print 2018

 
Last update Publications 11.12.2021